CENTER STREET INVESTMENTS, LLC
1 Documents in Project
Summary
SCH Number
2025091083
Public Agency
California Department of Cannabis Control
(DCC)
Document Title
CENTER STREET INVESTMENTS, LLC
Document Type
NOE - Notice of Exemption
Received
Posted
9/24/2025
Document Description
The Project will consist of an existing medical cannabis manufacturing facility located at 8191 CENTER ST, LA MESA, CA 91942. The APN is 494-010-15-00. It will operate out of an existing building on a 7685 SF site at the southwest corner of Center Street and Commercial Street. The manufacturing activities will occupy 2520 SF within the existing one-story building. There will only be cannabis manufacturing activities on site.
Contact Information
Name
CALVIN YEE
Agency Name
DEPARTMENT OF CANNABIS CONTROL
Job Title
ENVIRONMENTAL SCIENTIST
Contact Types
Lead/Public Agency
Phone
Location
Cities
La Mesa
Counties
San Diego
Regions
Southern California
Parcel #
494-010-15-00
Notice of Exemption
Exempt Status
Categorical Exemption
Type, Section or Code
[Class 32 Categorical Exemption Cal. Code Regs,. Title 14, §15332
Reasons for Exemption
The Department of Cannabis Control has determined that the project is a Class 32 Categorical Exemption Project.
Class 32 Categorical Exemptions consist of the environmentally benign infill projects that are consistent with the General Plan and Zoning requirements. This class is not intended for projects that would result in any significant traffic, noise, air quality, or water quality impacts. This exemption is not limited to any use type and may apply to residential, commercial, industrial, public facility, and/or mixed-use projects. None of the exceptions to the exemption defined in Section 15300.2 apply to the Project.
Attachments
Notice of Exemption
Disclaimer: The Governor’s Office of Land Use and Climate Innovation (LCI) accepts no responsibility for the content or accessibility of these documents. To obtain an attachment in a different format, please contact the lead agency at the contact information listed above. For more information, please visit LCI’s Accessibility Site.